Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: PROTEIN IN URINE; BLOOD IN URINE; VOMITING; HEADACHE; ABDOMINAL PAIN; This spontaneous report received from a patient concerned a 60 year old female. The patient''s height, and weight were not reported. The patient''s concurrent conditions included type 2 diabetes, rheumatoid arthritis, systemic lupus erythematosus, obesity, stage 2 chronic kidney disease, and psoriatic arthritis. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 041A21A expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. Concomitant medications included nitrofurantoin for blood in urine, and protein in urine. On 11-APR-2021 04:00, the subject experienced abdominal pain. On 11-APR-2021 09:00, the subject experienced vomiting. On 11-APR-2021 09:00, the subject experienced headache. On 14-APR-2021, the subject experienced protein in urine. On 14-APR-2021, the subject experienced blood in urine. Laboratory data included: Urinalysis (NR: not provided) positive for blood, positive for protein. Laboratory data (dates unspecified) included: Lupus anticoagulant positive (NR: not provided) positive. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from abdominal pain on 12-APR-2021, was recovering from headache, and vomiting, and the outcome of protein in urine and blood in urine was not reported. This report was non-serious.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166